cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells
- PMID: 2174560
- PMCID: PMC55163
- DOI: 10.1073/pnas.87.23.9353
cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells
Abstract
In this report, we explore the nature of the inductive stimuli leading to expression of the divergently regulated lymphokines interleukin 2 (IL-2) and interleukin 4 (IL-4). Elevation of cAMP levels blocks IL-2 induction while sparing IL-4 induction. These effects are gene-specific, not cell-specific, and can be observed in the same cells. Transient transfection experiments using murine IL-2 regulatory sequences to drive expression of a reporter gene show at least part of the inhibition to act at the transcriptional level. The possible biological significance of these results is indicated by the observation that representative type 2 helper T-cell lines maintain significantly higher levels of cAMP per cell than a type 1 helper T-cell line. Fresh splenic CD4+ T cells, which preferentially make IL-2, have particularly low levels of cAMP per cell and a low capacity to elevate cAMP in response to forskolin. However, their response to forskolin increases significantly after several days of stimulation. These results suggest a potential link between differential cAMP regulation and the divergence of memory T cells into effector subsets.
Similar articles
-
Interleukin 2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinatorial transcription roles.J Exp Med. 1994 Mar 1;179(3):931-42. doi: 10.1084/jem.179.3.931. J Exp Med. 1994. PMID: 8113685 Free PMC article.
-
Prostaglandin E2 and other cyclic AMP elevating agents inhibit interleukin 2 gene transcription by counteracting calcineurin-dependent pathways.J Exp Med. 1993 Nov 1;178(5):1813-7. doi: 10.1084/jem.178.5.1813. J Exp Med. 1993. PMID: 7693857 Free PMC article.
-
Interleukin-1 synergy with phosphoinositide pathway agonists for induction of interleukin-2 gene expression: molecular basis of costimulation.Mol Cell Biol. 1990 Dec;10(12):6325-34. doi: 10.1128/mcb.10.12.6325-6334.1990. Mol Cell Biol. 1990. PMID: 2174106 Free PMC article.
-
Toward the molecular biology of IL-2.Contemp Top Mol Immunol. 1985;10:35-61. doi: 10.1007/978-1-4684-4838-2_2. Contemp Top Mol Immunol. 1985. PMID: 3884258 Review. No abstract available.
-
Fluorescence-based monitoring of interleukin-2 gene expression.Immunol Rev. 1991 Feb;119:95-103. doi: 10.1111/j.1600-065x.1991.tb00579.x. Immunol Rev. 1991. PMID: 1904398 Review. No abstract available.
Cited by
-
Peripheral Dopamine Controlled by Gut Microbes Inhibits Invariant Natural Killer T Cell-Mediated Hepatitis.Front Immunol. 2018 Oct 17;9:2398. doi: 10.3389/fimmu.2018.02398. eCollection 2018. Front Immunol. 2018. PMID: 30386344 Free PMC article.
-
Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production.J Exp Med. 1995 Feb 1;181(2):775-9. doi: 10.1084/jem.181.2.775. J Exp Med. 1995. PMID: 7836930 Free PMC article.
-
Sympathetic-mediated activation versus suppression of the immune system: consequences for hypertension.J Physiol. 2016 Feb 1;594(3):527-36. doi: 10.1113/JP271516. Epub 2015 Dec 30. J Physiol. 2016. PMID: 26830047 Free PMC article. Review.
-
Cyclic adenosine monophosphate involvement in low-dose cyclophosphamide-reversed immune evasion in a mouse lymphoma model.Cell Mol Immunol. 2012 Nov;9(6):482-8. doi: 10.1038/cmi.2012.34. Epub 2012 Sep 24. Cell Mol Immunol. 2012. PMID: 23000689 Free PMC article.
-
Interleukin-2 transcription is regulated in vivo at the level of coordinated binding of both constitutive and regulated factors.Mol Cell Biol. 1994 Mar;14(3):2159-69. doi: 10.1128/mcb.14.3.2159-2169.1994. Mol Cell Biol. 1994. PMID: 8114746 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials